K244036 is an FDA 510(k) clearance for the Heel Incision Safety Lancet (SteriHeel 2). This device is classified as a Single Use Only Blood Lancet With An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code FMK).
Submitted by SteriLance Medical (Suzhou), Inc. (Suzhou, CN). The FDA issued a Cleared decision on February 26, 2025, 58 days after receiving the submission on December 30, 2024.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Non-reusable Base (including An Integral Sharps Injury Prevention Feature) That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. The Integral Sharps Injury Prevention Feature Allows The Device To Be Used Once And Then Renders It Inoperable And Incapable Of Further Use..